224 related articles for article (PubMed ID: 31645017)
1. Pituitary tumour fibroblast-derived cytokines influence tumour aggressiveness.
Marques P; Barry S; Carlsen E; Collier D; Ronaldson A; Awad S; Dorward N; Grieve J; Mendoza N; Muquit S; Grossman AB; Balkwill F; Korbonits M
Endocr Relat Cancer; 2019 Dec; 26(12):853-865. PubMed ID: 31645017
[TBL] [Abstract][Full Text] [Related]
2. Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours.
Marques P; Barry S; Carlsen E; Collier D; Ronaldson A; Awad S; Dorward N; Grieve J; Mendoza N; Muquit S; Grossman AB; Balkwill F; Korbonits M
Acta Neuropathol Commun; 2019 Nov; 7(1):172. PubMed ID: 31703742
[TBL] [Abstract][Full Text] [Related]
3. The expression of neural cell adhesion molecule and the microenvironment of pituitary neuroendocrine tumours.
Marques P; Barry S; Carlsen E; Collier D; Ronaldson A; Grieve J; Dorward N; Mendoza N; Nair R; Muquit S; Grossman AB; Korbonits M
J Neuroendocrinol; 2021 Dec; 33(12):e13052. PubMed ID: 34708902
[TBL] [Abstract][Full Text] [Related]
4. The role of the tumour microenvironment in the angiogenesis of pituitary tumours.
Marques P; Barry S; Carlsen E; Collier D; Ronaldson A; Dorward N; Grieve J; Mendoza N; Nair R; Muquit S; Grossman AB; Korbonits M
Endocrine; 2020 Dec; 70(3):593-606. PubMed ID: 32946040
[TBL] [Abstract][Full Text] [Related]
5. SDF-1α/MicroRNA-134 Axis Regulates Nonfunctioning Pituitary Neuroendocrine Tumor Growth
Wang X; Fang Y; Zhou Y; Guo X; Xu K; Li C; Zhang J; Hong Y
Front Endocrinol (Lausanne); 2020; 11():566761. PubMed ID: 33362712
[TBL] [Abstract][Full Text] [Related]
6. Single-cell sequencing of PIT1-positive pituitary adenoma highlights the pro-tumour microenvironment mediated by IFN-γ-induced tumour-associated fibroblasts remodelling.
Lyu L; Jiang Y; Ma W; Li H; Liu X; Li L; Shen A; Yu Y; Jiang S; Li H; Zhou P; Yin S
Br J Cancer; 2023 Apr; 128(6):1117-1133. PubMed ID: 36631635
[TBL] [Abstract][Full Text] [Related]
7. The tumour microenvironment of pituitary neuroendocrine tumours.
Marques P; Grossman AB; Korbonits M
Front Neuroendocrinol; 2020 Jul; 58():100852. PubMed ID: 32553750
[TBL] [Abstract][Full Text] [Related]
8. A mediator of phosphorylated Smad2/3, evodiamine, in the reversion of TAF-induced EMT in normal colonic epithelial cells.
Yang W; Gong X; Wang X; Huang C
Invest New Drugs; 2019 Oct; 37(5):865-875. PubMed ID: 30488243
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.
Goulet CR; Champagne A; Bernard G; Vandal D; Chabaud S; Pouliot F; Bolduc S
BMC Cancer; 2019 Feb; 19(1):137. PubMed ID: 30744595
[TBL] [Abstract][Full Text] [Related]
10. Trichostatin a inhibits phenotypic transition and induces apoptosis of the TAF-treated normal colonic epithelial cells through regulation of TGF-β pathway.
Huang C; Wu XF; Wang XL
Int J Biochem Cell Biol; 2019 Sep; 114():105565. PubMed ID: 31278993
[TBL] [Abstract][Full Text] [Related]
11. Distribution of E- and N-cadherin in subgroups of non-functioning pituitary neuroendocrine tumours.
Øystese KAB; Casar-Borota O; Berg-Johnsen J; Berg JP; Bollerslev J
Endocrine; 2022 Jun; 77(1):151-159. PubMed ID: 35674926
[TBL] [Abstract][Full Text] [Related]
12. Disulfiram mediated anti-tumour effect in pituitary neuroendocrine tumours by inducing cuproptosis.
Huang N; Feng Y; Liu Y; Zhang Y; Liu L; Zhang B; Zhang T; Su Z; Xue L; Wu ZB
Int Immunopharmacol; 2024 Jun; 134():112159. PubMed ID: 38692018
[TBL] [Abstract][Full Text] [Related]
13. PITX2 Expression in Non-functional Pituitary Neuroendocrine Tumor with Cavernous Sinus Invasion.
Tamura R; Ohara K; Morimoto Y; Kosugi K; Oishi Y; Sato M; Yoshida K; Toda M
Endocr Pathol; 2019 Jun; 30(2):81-89. PubMed ID: 30903445
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Proteomic-Based Molecular Characterizations of Invasive and Noninvasive Somatotroph PitNETs.
Chen M; Duan L; Sun W; Guo Z; Miao H; Yu N; Yang S; Wang L; Gong F; Yao Y; Zhu H
Neuroendocrinology; 2023; 113(9):971-986. PubMed ID: 37253344
[TBL] [Abstract][Full Text] [Related]
15. HSPB1 promotes tumor invasion by inducing angiogenesis in PitNETs.
Li B; Zhao S; Chen Y; Gao H; Xie W; Wang H; Zhao P; Li C; Zhang Y
Endocr Relat Cancer; 2024 Jun; 31(6):. PubMed ID: 38457246
[TBL] [Abstract][Full Text] [Related]
16. Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.
Mete O; Alshaikh OM; Cintosun A; Ezzat S; Asa SL
Endocr Pathol; 2018 Dec; 29(4):332-338. PubMed ID: 30215160
[TBL] [Abstract][Full Text] [Related]
17. Differential expression levels of β-catenin are associated with invasive behavior of both functional and non-functional pituitary neuroendocrine tumor (PitNET).
Taghavi SF; Ghorbani M; Panahi M; Nazem S; Karimi M; Salimi V; Tavakoli-Yaraki M
Mol Biol Rep; 2023 Aug; 50(8):6425-6434. PubMed ID: 37326745
[TBL] [Abstract][Full Text] [Related]
18. Macrophage colony-stimulating factor potentially induces recruitment and maturation of macrophages in recurrent pituitary neuroendocrine tumors.
Matsuzaki H; Komohara Y; Yano H; Fujiwara Y; Kai K; Yamada R; Yoshii D; Uekawa K; Shinojima N; Mikami Y; Mukasa A
Microbiol Immunol; 2023 Feb; 67(2):90-98. PubMed ID: 36461910
[TBL] [Abstract][Full Text] [Related]
19. FSH Levels Are Related to E-cadherin Expression and Subcellular Location in Nonfunctioning Pituitary Tumors.
Kolnes AJ; Øystese KAB; Olarescu NC; Ringstad G; Berg-Johnsen J; Casar-Borota O; Bollerslev J; Jørgensen AP
J Clin Endocrinol Metab; 2020 Aug; 105(8):2587-94. PubMed ID: 32421791
[TBL] [Abstract][Full Text] [Related]
20. Aberrant TIMP-1 production in tumor-associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma.
Duch P; Díaz-Valdivia N; Gabasa M; Ikemori R; Arshakyan M; Fernández-Nogueira P; Llorente A; Teixido C; Ramírez J; Pereda J; Chuliá-Peris L; Galbis JM; Hilberg F; Reguart N; Radisky DC; Alcaraz J
Cancer Sci; 2024 May; 115(5):1505-1519. PubMed ID: 38476010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
